Our Technology

In antibody discovery it is important to quantify a range of properties to determine if the candidate antibody is suitable. SMi enables the simultaneous detection of target engagement, affinity (Kd), association (kon) and dissociation (koff), as well as non-specific binding.

There are range of molecules that are routinely assessed during vaccines development. These include antibody isotypes, cytokines and other immune regulators. SMi’s microarrays allow multiple assays on a single sample.

Imagine being able to visualise every residue in a protein or every nucleotide in an RNA or DNA strand. With the resolution SMi can offer, this is now possible.

If you can see an infectious microorganism, it is irrefutable evidence of its presence in a patient sample. Imagine specifically identifying a range of different microorganisms at the same time. The next time you have a cough, your physician will be able to tell you what you have, what you don’t have and whether there is more than one infection causing your symptoms.

Catching cancer at an early stage is key to a successful outcome and could be achieved with a simple, fast, accurate and inexpensive cancer screen. Blood tests are seen as a highly desirable solution as they are minimally invasive and researchers have worked hard to identify blood biomarkers that can help with diagnosis. The challenge with current methods is their slow speed, the coordination of results from multiple tests and the need to perform them for large numbers of patient samples. As SMi's technology can simultaneously detect, distinguish, and count different types of single molecules, it is the perfect choice for such an application.

With high resolution it is possible to directly detect and quantify the levels of countless types of molecules. These can be biological substances, environmental contaminants, illegal substances or dangerous chemicals.